| Bioactivity | Glycyl-L-histidyl-L-lysine is a tripeptide consisting of glycine, L-histidine and L-lysine residues joined in sequence. Glycyl-L-histidyl-L-lysine is a hepatotropic immunosuppressor and shows anxiolytic effect. Glycyl-L-histidyl-L-lysine and its copper complexes show good skin tolerance[1][2][3]. |
| Invitro | Glycyl-L-histidyl-L-lysine and its copper complexes and saccharomyces/copper ferment on secretion of pro-inflammatory IL-6 in normal human dermal fibroblasts NHDF cell line[1].Glycyl-L-histidyl-L-lysine and its copper complexes decreases TNF-α-dependent IL-6 secretion in fibroblasts[1]. |
| Name | Glycyl-L-histidyl-L-lysine |
| CAS | 49557-75-7 |
| Formula | C14H24N6O4 |
| Molar Mass | 340.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Glycyl-L-histidyl-L-lysine
CAS: 49557-75-7 F: C14H24N6O4 W: 340.38
Glycyl-L-histidyl-L-lysine is a tripeptide consisting of glycine, L-histidine and L-lysine residues joined in sequence.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.